LAD-191

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameLAD-191
Drug Alias NameLAD191LAD-191
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesHidradenitis Suppurativa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlmirall Sa
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHidradenitis Suppurativa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A